Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.Share:More In Science Novo Nordisk Slashes Insulin Drug Prices By 75%Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.No more stories
Novo Nordisk Slashes Insulin Drug Prices By 75%Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.
